Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-02

Clinical Trial Update: ComparisoN of ticAgrelor vs. Clopidogrel in endoTHeliAl Function of COPD patieNts [Phase 2]

View source ↗

Summary

Phase 2 trial comparing ticagrelor versus clopidogrel evaluated endothelial function in patients with chronic obstructive pulmonary disease and coronary artery …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BRILINTA (ticagrelor)
  • Plavix (clopidogrel)

Snippet

Sponsor: University Hospital of Ferrara | Conditions: Coronary Artery Disease, Chronic Obstructive Pulmonary Disease | Phase 2 | Status: COMPLETED